Related references
Note: Only part of the references are listed.Disrupted BRCA1-PALB2 interaction induces tumor immunosuppression and T-lymphocyte infiltration in HCC through cGAS-STING pathway
Hui Ma et al.
HEPATOLOGY (2023)
Frontline treatment approaches in TP53-aberrant mantle cell lymphoma
Nikesh N. Shah et al.
LEUKEMIA & LYMPHOMA (2023)
EBV-Mir-BART5-5p targets p53 independent pathway in cytoplasm: Potential role in EBV lymphomagenesis
Wei-Ting Wang et al.
GENES & DISEASES (2023)
Combined Inactivation of CTPS1 and ATR Is Synthetically Lethal to MYC-Overexpressing Cancer Cells
Zhe Sun et al.
CANCER RESEARCH (2022)
Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter Open-Label, Single-Arm, Phase II Trial
Eva Gine et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1
Yuxiang Lin et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2022)
Cancer metabolism and tumor microenvironment: fostering each other?
Yiyuan Yuan et al.
SCIENCE CHINA-LIFE SCIENCES (2022)
Mantle cell lymphoma in 2022-A comprehensive update on molecular pathogenesis, risk stratification, clinical approach, and current and novel treatments
Preetesh Jain et al.
AMERICAN JOURNAL OF HEMATOLOGY (2022)
A Novel Synthetic Lethal Approach to Target MYC-Driven Cancers
Roman M. Chabanon et al.
CANCER RESEARCH (2022)
De novo pyrimidine synthesis fuels glycolysis and confers chemoresistance in gastric cancer
Daochuan He et al.
CANCER LETTERS (2022)
Metabolic Reprogramming in Hematologic Malignancies: Advances and Clinical Perspectives
Zhuoya Yu et al.
CANCER RESEARCH (2022)
CTPS1 suppresses proliferation and migration in colorectal cancer cells
Fahong Wu et al.
CELL CYCLE (2022)
Mantle-Cell Lymphoma
James O. Armitage et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant glioma
Diana D. Shi et al.
CANCER CELL (2022)
Is There Still a Role for Transplant for Patients with Mantle Cell Lymphoma (MCL) in the Era of CAR-T Cell Therapy?
Amer Beitinjaneh et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2022)
ATM inhibition enhances cancer immunotherapy by promoting mtDNA leakage and cGAS/STING activation
Mengjie Hu et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Epstein-Barr Virus Induced Cytidine Metabolism Roles in Transformed B-Cell Growth and Survival
Jin Hua Liang et al.
MBIO (2021)
The Cytosolic DNA-Sensing cGAS-STING Pathway in Cancer
John Kwon et al.
CANCER DISCOVERY (2020)
A non-proliferative role of pyrimidine metabolism in cancer
Aarif Siddiqui et al.
MOLECULAR METABOLISM (2020)
Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy
Jiaqi Li et al.
MOLECULES (2020)
Impaired lymphocyte function and differentiation in CTPS1-deficient patients result from a hypomorphic homozygous mutation
Emmanuel Martin et al.
JCI INSIGHT (2020)
Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer
Triparna Sen et al.
CANCER DISCOVERY (2019)
Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma
Liang Zhang et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Targeting pyrimidine synthesis accentuates molecular therapy response in glioblastoma stem cells
Xiuxing Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer
Tuo Li et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Understanding the Intersections between Metabolism and Cancer Biology
Matthew G. Vander Heiden et al.
CELL (2017)
Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression
Zhaoyong Li et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes
C. Y. Cheah et al.
ANNALS OF ONCOLOGY (2015)
CTP synthase 1 deficiency in humans reveals its central role in lymphocyte proliferation
Emmanuel Martin et al.
NATURE (2014)
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
Michael L. Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Low cytosine triphosphate synthase 2 expression renders resistance to 5-fluorouracil in colorectal cancer
Wen Lee Tan et al.
CANCER BIOLOGY & THERAPY (2011)
Structure of the synthetase domain of human CTP synthetase, a target for anticancer therapy
Petri Kursula et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2006)